All In Biotech

Drug Trial Radar · NCT07425210

Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPD

A Multicenter, Single-Arm, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Last checked: Nov 20, 2026Latest source record: Feb 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Mar 2026

Primary completion

Jul 2027

Study completion Aug 2027

Sponsor

Sponsor type
Industry
First posted
Feb 20, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical trial evaluates the long-term safety and efficacy of 0.75 mg HSK39004 Dry Powder Inhaler administered twice daily for 52 weeks in subjects aged 40 to 80 years with moderate-to-severe stable chronic obstructive pulmonary disease (COPD), including both newly enrolled and those who have completed prior participation in the HSK39004-201, HSK39004-T1-201, or HSK39004-T1-202 studies as a long-term extension.

Conditions

  • Chronic Obstructive Lung Disease (COLD)

Interventions

  • HSK39004 Dry Powder Inhaler -0.75mg BIDDrug

    HSK39004 Dry Powder Inhaler: Inhale through the mouth, 0.75mg each time, twice a day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment-emergent adverse event (TEAE) incidenceTime frame: From week 1 to week 53

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Guizhou Provincial People's Hospital

    Guiyang, Guizhou, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.